Supplemental material
Open access
12,990
Views
11
CrossRef citations to date
0
Altmetric
Report
Improved therapeutic index of an acidic pH-selective antibody
Peter S. Leea Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, CA, USACorrespondence[email protected]
https://orcid.org/0000-0002-8745-4034View further author information
Katherine G. MacDonaldb Immuno-Oncology Research, Bristol Myers Squibb, Redwood City, CA, USACorrespondence[email protected]
View further author information
, View further author information
Evan Massib Immuno-Oncology Research, Bristol Myers Squibb, Redwood City, CA, USAView further author information
, Pamela V. Chewc Oncology Biology, Gilead Sciences, Foster City, CA, USAView further author information
, Christine Beed Discovery Biology, Frontier Medicines, South San Francisco, CA, USAView further author information
, Padma Perkinsb Immuno-Oncology Research, Bristol Myers Squibb, Redwood City, CA, USAView further author information
, Bryant Chaue Kyverna, Synthetic Biology, Emeryville, CA, USAView further author information
, Kent Thudiumb Immuno-Oncology Research, Bristol Myers Squibb, Redwood City, CA, USAView further author information
, Jack Lohref In Vivo Pharmacology, Bristol Myers Squibb, Redwood City, CA, USAView further author information
, Pradyot Nandig Pharmaceutical Candidate Optimization, Bristol Myers Squibb, Lawrenceville, NJ, USAView further author information
, Ekaterina G. Deyanovag Pharmaceutical Candidate Optimization, Bristol Myers Squibb, Lawrenceville, NJ, USAView further author information
, Ishita Barmanh Therapeutic Discovery, 3T Biosciences, South San Francisco, CA, USAView further author information
, Olafur Gudmundssong Pharmaceutical Candidate Optimization, Bristol Myers Squibb, Lawrenceville, NJ, USAView further author information
, Gavin Dollingera Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, CA, USAView further author information
, Tim Sprouli In Vivo Pharmacology, UNITY Biotechnology, South San Francisco, CA, USAView further author information
, John J. Engelhardtj Immuno-Oncology Discovery, Abbvie, South San Francisco, CA, USAView further author information
, Pavel Stropk Biologics Discovery, Tallac Therapeutics, Burlingame, CA, USAView further author information
& Arvind Rajpall Large Molecule Drug Discovery, Genentech Research and Early Development, South San Francisco, CA, USAView further author information
show all
Article: 2024642
|
Received 16 Nov 2021, Accepted 28 Dec 2021, Published online: 22 Feb 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.